© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 12, 2022
A national survey found that patients are willing to try medical cannabis products as potential treatments of their condition. Additionally, some already use over-the-counter cannabis products.
January 11, 2022
Free coverage starts January 15
January 10, 2022
Here’s a preview of the featured content to watch for this week on Drug Topics®.
January 07, 2022
As change continues to sweep the industry, we take a closer look at the trends that may be coming to a pharmacy near you.
Here’s a roundup of the latest news from Drug Topics®.
January 06, 2022
Clinicians are seeking ways to reduce opioid exposure in a variety of settings. Could the use of acetaminophen before opioid use reduce opioid treatment duration in the inpatient setting?
As pharmacists administer more immunizations than ever, managers must provide a larger tray (pharmacy technicians) or smaller plates (fewer responsibilities) to balance things out.
January 05, 2022
January 03, 2022
The FDA approved efgartigimod, which is being sold under the brand name Vyvgart and could foment price competition with Soliris (eculizumab) and other treatments usually reserved for severe or refractory cases.
December 30, 2021
Let’s raise a glass to all the pharmacy owners who are improving patient health outcomes by providing innovative services.